Eye Meridian Clear Drop Eyedrops - 12mL

A Century of Heritage, Made in Hong Kong

Green Treasure [Mu Jing Eye Drops] inherits the essence of the Qing Dynasty TCM ophthalmology masterpiece "Mu Jing Da Cheng," a classic product with a century of heritage and long-term clinical validation. It can protect and treat eye diseases. The product is suitable for men, women, and children. It is effective for adolescent myopia; dry eyes, visual fatigue, presbyopia, and photoelectric eye inflammation in young and middle-aged people; and it is effective for the increasing number of fundus diseases (such as diabetic retinopathy, maculopathy, cataracts, glaucoma, etc.). It is also effective in preventing eye and brain stroke. It is a rare pure natural Chinese herbal eye drop with both protective and therapeutic properties in the international market.

Hongkong · Swiss Green Treasure Pharmaceuticals is a pharmaceutical company with a long history of specializing in the research and development of natural Chinese herbal ophthalmic medications, consistently investing billions of dollars in the development of ophthalmic medicines. With nearly three decades of development, they possess proprietary, original core technologies. They manufacture their exclusive product, Green Treasure Eye Drops, using 100% natural Chinese herbs and steroid-free. Through unprecedented standardization, Green Treasure Eye Drops undergoes rigorous, almost stringent, sterility manufacturing, testing, and authentication, officially becoming a registered Chinese patent medicine in Hong Kong (Chinese patent medicine registration number: HKP-12333). This product is potentially the only Chinese herbal eye drop registered with the Hong Kong Department of Health for Chinese patent medicines, and a rare product worldwide that uses natural Chinese herbs to treat ocular diseases such as diabetic retinopathy, maculopathy, cataracts, and glaucoma.

In recent years, the number of patients with diabetes and various eye diseases has been increasing rapidly. Government departments in various countries have realized that this situation will lead to a large number of people losing their ability to move due to visual impairment. From a national perspective, the country will lose a huge amount of productivity and GDP growth, and a large number of social problems will arise, as well as huge medical expenses. As we enter the aging age, the prevention and treatment of macular degeneration, glaucoma, and cataracts will be put on the agenda. Therefore, various eye diseases and fundus diseases have become key research and development projects in various countries.

The traditional Chinese medicine theory of promoting blood circulation and removing blood stasis is consistent with the etiology and pathogenesis of fundus diseases.

The fundus is composed of the retina, blood vessels, optic nerve head, optic nerve fibers, the macula on the retina, and the choroid behind the retina. Pathologies in these areas are collectively referred to as fundus diseases. Most fundus diseases, including diabetic retinopathy and macular degeneration, are caused by poor fundus circulation, edema, and bleeding. Treating these non-surgical problems is in line with Traditional Chinese Medicine's principle of "opening the meridians to promote blood circulation in the fundus," fully leveraging its unique expertise in ophthalmological care and treatment.

Green Treasure [Mujing Eye Drops] is a classic Traditional Chinese Medicine product that combines the essence of traditional Chinese medicine ophthalmology, featuring a refined formula, unique craftsmanship, rigorous testing, sophisticated treatment, and rapid efficacy. It contributes to solving today's world-class challenges in fundus ophthalmopathy.

Green Treasure【Eye Drops】– Chronological Records

(1) Inheriting a century of history, unique craftsmanship, and remarkable therapeutic effects;

(2) Since 1982, it has entered into modernization research and improvement and optimization;

(3) In 2003, transitional registration of Chinese patent medicines in Hong Kong began, and a series of tests and appraisals were carried out;

(4) In 2009, he received the National Basic Research Program of the Ministry of Science and Technology (No. 2009FY220100);

(5) In 2013, it became a key research and development project of the National Twelfth Five-Year Plan (No.: 2013BAH08F04, 2013BAH08F00);

(6) In 2013, he published a paper at the 51st World Congress of Traditional Medicine of the World Health Organization and was awarded the Outstanding Doctor Award.

(7) In 2014, we received national research funding to establish a research platform for project research and development.

(8) In October 2015, CCTV, China Central Television, conducted a half-hour interview on Green Treasure Eye Drops.

(9) Selected products for China’s military logistics support new technologies and equipment in 2015.

(10) In January 2016, the Hong Kong Department of Health officially issued the Chinese patent medicine registration certificate (No.: HKP-12333).